Quality of Life Differences in Female and Male Patients with Fecal Incontinence by Mundet, Lluís et al.
94
Quality of Life Differences in Female and Male 
Patients with Fecal Incontinence 
Lluís Mundet,1,2* Yolanda Ribas,3 Sandra Arco,4,5 and Pere Clavé1,2,6
1Unitat d’Exploracions Funcionals Digestives, Department of Surgery, Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró, Spain; 
2Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain; 3Department of Surgery, Consorci Sanitari de 
Terrassa, Terrassa, Spain; 4Department of Nursing, Badalona Serveis Assistencials, Badalona, Spain; 5Escola Superior de Ciències de la Salut, 
Tecnocampus, Mataró, Spain; and 6Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de 
Salud Carlos III, Barcelona, Spain
Background/Aims
To explore and compare quality of life (QoL) differences in female and male patients with fecal incontinence.
Methods
Ninety-one patients with fecal incontinence (60 women, mean (SD) age 64.13 (9.72) years; 31 men, mean (SD) age 63.61 (13.33) 
years) were assessed for pathophysiology (anorectal manometry and ultrasound), clinical severity (Wexner and Vaizey scales), QoL 
(Fecal Incontinence Quality of Life Score [FIQL]) and health status (EQ-5D).
Results
External and internal anal sphincter impairment rates were 96.5% and 70.2%, respectively, in women, compared to 30% and 43.3% 
respectively in men (P < 0.05). Clinical severity was similar in both sexes, with mean (SD) Wexner scores of 10.95 (4.35) for women 
and 9.81 (4.30) for men, and mean (SD) Vaizey scores of 13.27 (4.66) for women and 11.90 (5.22) for men. Scores for women were 
significantly lower for all FIQL depression and coping subscales (P < 0.001) and the EQ-5D depression subscale (P < 0.01). EQ-5D 
index was 0.687 (0.20) for women and 0.835 (0.15) for men (P < 0.001). QoL was negatively affected by female gender (–1.336), 
anxiety/depression (–1.324) and clinical severity (–0.302), whereas age had a positive impact (0.055 per year) (P < 0.01). 
Conclusions
The pathophysiology of fecal incontinence differed between the sexes. For similar severity scores, impact on QoL was higher in 
women. Gender had the highest impact on QoL compared to other factors. QoL measurements should be part of assessment and 
treatment protocols.
(J Neurogastroenterol Motil 2016;22:94-101)
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Introduction  
Fecal incontinence is defined as an involuntary loss of solid, 
liquid or gas stool and implies a social problem for the affected 
individual.1,2 Although prevalence is estimated to be 1.4% to 3% 
of community-dwelling adults,3-5 higher figures of up to 12% have 
been reported.6,7 It is thought that prevalence may be underesti-
mated because patients are often reluctant to report their symp-
toms.8 Australian,8 New Zealand,9 Spanish,10 and Korean11 studies 
have reported prevalence rates of 15%, 12.4%, 10.8%, and 6.4% 
respectively, for random samples drawn from the general popula-
tion. Although prevalence in women is thought to be higher than 
in men,4 usually as a consequence of childbirth-related injuries,12-14 
some studies have failed to find clear epidemiological differences 
between the sexes, whereas other studies have actually reported 
higher prevalence rates for men than for women.8 In a systematic 
review, Chiarelli et al15 found very similar prevalence rates for both 
sexes. Moreover, it has been suggested that prevalence data may be 
distorted by men being more unwilling to report fecal incontinence 
than women.4,8
Fecal continence is a complex physiological function that in-
volves anatomical and functional integrity of the anal sphincter, 
anal and rectal sensitivity and intrinsic and extrinsic motor innerva-
tion16; fecal consistency also plays a role, given that loose and liquid 
stools are less easily retained. Fecal incontinence is regarded as a 
multifactorial condition as it is not usually associated with just one 
pathogenic abnormality.17 Evaluation of the health impact is a clini-
cal challenge, as proper assessment of patients needs to take into 
account the pathophysiology, pathogenesis, clinical severity, and 
quality of life (QoL) dimensions. Pathophysiological evaluation 
aims to determine the functional and structural elements implicated 
in fecal incontinence. Standard procedures implemented in good 
clinical practice18 are anorectal manometry (ARM) and ultrasound 
(US) imaging. Injuries to the external anal sphincter (EAS) are as-
sociated with urge fecal incontinence, whereas a damaged internal 
anal sphincter (IAS) or defective anal endovascular cushions may 
cause passive fecal incontinence.19,20 As for pathogenesis, two clas-
sifications (Thekkinkattil et al21 and Muñoz-Duyos et al12) can be 
used in clinical practice. Clinical severity is usually assessed by the 
Cleveland Clinic Incontinence Score22 or the St. Mark’s Inconti-
nence Score,23 commonly known as the Wexner and Vaizey scales, 
respectively. Finally, the specific Fecal Incontinence Quality of Life 
scale24 (FIQL) or a more general instrument like the EQ-5D25 
may be used to assess the impact on QoL.
The QoL of people with fecal incontinence is usually severely 
affected26-30 and the impact on their life in general can be devastat-
ing; in many cases, the patient experiences severe psychological suf-
fering and social isolation. Although QoL for patients with fecal in-
continence has been researched, little has been said about the impact 
of gender. Few studies of community-dwelling patients have tried 
to explore this aspect and results have varied: one study did not find 
differences between genders,30 another found slightly better QoL in 
women,31 in a third, higher coping and embarrassment scores were 
associated with men,32 and a fourth study7 reported that women had 
a significantly lower average QoL; in this latter study, however, the 
FIQL dimensions most affected were not specified. 
Knowledge of how gender affects QoL can be of great impor-
tance when treating and counseling patients. The latter is key to 
helping them deal with this condition.
The main aim of our study was to assess QoL differences in 
women and men with fecal incontinence attending our motility 
unit and living in the community. Our hypothesis was that women 
have poorer QoL compared to men and consequently score lower 
in FIQL. Secondary aims were to assess differences in male and 
female pathogenesis and pathophysiology and their impact on QoL 
and to assess the effectiveness of the Wexner and Vaizey scales in 
measuring clinical severity.
Materials and Methods  
Study Design
This cross-sectional observational study included patients with 
fecal incontinence attending the Motility Unit of the Hospital de 
Mataró, a public secondary hospital that provides health care to a 
population of 300 000. Patients were prospectively recruited be-
tween February and November 2012. The sample size was estimat-
ed by using GRANMO software, ver. 7.12 (IMIM, Barcelona, 
Spain). Assuming an Alpha risk of 0.05 and a Beta risk of 0.20, a 
SD of 0.6 (for FIQL) and a minimum expected difference of 0.4, 
a group of 54 women and a group of 27 men were needed. The 
study was approved by the Hospital Ethics Committee; all patients 
provided written informed consent and the study was performed in 
accordance with the ethical standards laid down in the 1964 Decla-
ration of Helsinki and its later amendments. 
Patient Profiles
Data was collected on demographics, including socioeconomic, 
educational level and marital status. Complete medical histories 
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were also recorded, taking into account comorbidities and possible 
risk factors for fecal incontinence. 
Pathophysiology, Pathogenesis, and Clinical Severity 
The ARM study was performed using a water-perfused 
5-mm-diameter catheter with 6 recording sites arranged at 60o (Mui 
Scientific, Mississauga, Ontario, Canada), and a second catheter 
with 4 longitudinal recording sites separated at 1-cm intervals with 
spiroidal distribution and a latex balloon at the top (Mui Scientific), 
as previously described.33 Data was captured using a Polygraph ID 
multi-parametric recorder (Medtronic, Minneapolis, USA) and 
the Polygram NET data acquisition software (Medtronic). Proce-
dures and measurements were those recommended in the Spanish 
Digestive Motility Group (rupo Español de Motilidad Digestiva 
[GEMD]) protocol.33 IAS integrity and the presence of tears in 
the puborectalis muscle and the EAS34 were assessed using a Hita-
chi ultrasound machine equipped with a 360o endoanal 10-MHz 
transducer (Hitachi Medical Corporation, Tokyo, Japan). 
Pathogenesis was assessed using the Thekkinkattil et al21 and 
Muñoz-Duyos et al12 fecal incontinence classifications. The Thek-
kinkattil classification considers four causes (traumatic, neuropathic, 
combined and idiopathic), whereas the Muñoz-Duyos classification 
considers 6 causes (obstetric, muscular non-obstetric, neuropathic, 
congenital, multifactorial, and idiopathic). From the perspective 
of our study, the main difference between the two classifications is 
that the Thekkinkattil “trauma” category is broken down into “ob-
stetric” and “muscular non-obstetric” causes in the Muñoz-Duyos 
classification, a distinction that broadly mirrors a risk-factor differ-
ence between the sexes (fecal incontinence in women is frequently 
childbirth-related). 
Stool consistency was assessed using the Bristol stool chart.35 
Clinical severity was assessed using the Wexner scale22 (0 to 20, 
where 0 indicates perfect continence and 20 indicates total inconti-
nence) and the Vaizey scale (0 to 24, where 0 indicates perfect conti-
nence and 24 indicates severe incontinence). The Vaizey scale aimed 
to improve the severity assessment of the Wexner scale by taking 
into account the ability to defer defecation and the use of antidiar-
rheals.23
Impact on Health and Quality of Life 
The validated Spanish version36 of the FIQL was used to assess 
the impact of fecal incontinence on QoL. The FIQL consists of 29 
items covering the 4 subscales of lifestyle, behavior, depression and 
embarrassment, each scored between 0 (greatest negative impact) 
and 4 (no impact).24
General health was assessed by the EuroQoL 5-dimensional 
questionnaire (EQ-5D), a widely used generic questionnaire that 
measures health-related QoL and health outcomes. It has been 
applied to a wide range of treatments and conditions, including fe-
cal incontinence.25,37,38 The EQ-5D is a self-reported description 
of a person’s current health in the 5 dimensions of mobility, self-
care, performance of usual activities, pain/discomfort, and anxiety/
depression. It also includes a visual analogue scale that scores self-
perceived health status on a scale ranging between 0 (worst imagin-
able health state) and 100 (best imaginable health state). The EQ-
5D descriptive system can be converted to single summary index, 
which ranges from 0 (worst health state) to 1 (best health state).
Statistical Methods 
Continuous variables were expressed as means (SD) and male-
female differences were compared using the Mann-Whitney test. 
Categorical variables were expressed as frequencies and percentages 
and were analyzed using the chi-square test or Fisher’s exact test. 
Correlations were calculated using the Pearson coefficient or Spear-
man’s rho. P-values of 0.05 or less were considered to be statistically 
significant. Multivariate regression analysis was used to assess the 
independent effects on QoL of sex, age, severity (Wexner score), 
and depression. Statistical analyses were conducted using SPSS ver-
sion 20.0 (IBM).
Results  
Patient Profiles and Risk Factors
A total of 91 patients were included in the study, 60 (65.9%) 
women and 31 (34.1%) men. Mean (SD) age was 64.13 (9.72) and 
63.61 (13.33) years for women and men, respectively, with no sig-
nificant difference between the sexes. Most patients (70.3%) were 
married; of the rest, 14.3% were widowed, 11% divorced and 4.4% 
single. Regarding the educational level, almost half (48.4%) had 
primary education, 23.1% had high school, 16.5% had no stud-
ies but could write and read, 8.8% had university education, and 
finally, 3.3% were illiterate. There were no significant differences in 
marital, educational and socioeconomic statuses between the sexes. 
The most common risk factors were childbirth for women and low 
anterior resection and pelvic radiotherapy for men (Table 1). Most 
frequent comorbidities were depression/anxiety and hypertension, 
with differences between both groups for depression/anxiety that 
was significantly higher in women (59.9% vs 29.0% in men, P < 
0.05).
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Pathophysiology, Pathogenesis, and Severity
Almost all the women, but less than one third of the men, had 
impaired EAS function during squeeze, and almost three quarters 
of the women and under half the men had impaired IAS function. 
Reduced rectal perception during balloon distension was signifi-
cantly more frequent in men. In contrast, no major differences were 
found between men and women regarding extrinsic EAS motor 
responses to increased intra-abdominal pressure20,39,40 (Table 2). In 
addition, 58.4% of our patients showed anorectal dyssynergia dur-
ing defecation attempts.
According to the Bristol stool chart, slightly more than 40% of 
the patients had loose or liquid stools, with 25.6% scoring 5 (soft 
tools), and 15.6% scoring 6 (mushy stools). No differences were 
observed between the sexes.
As for causes of fecal incontinence, direct injury to the sphincter 
muscles was the main cause in women, mostly as a result of child-
birth. Pathogenesis in men was mostly multifactorial but mainly 
caused by coloproctological surgery (Table 3).
Regarding clinical severity evaluations, there were no significant 
differences between men and women (Table 4). 









Childbirth 80.3% 96.6% (57) - -
Diabetes 18.9% 16.9% (10) 22.6% (7) 0.517
Irritable bowel syndrome 16.9% 18.6% (11) 9.7% (3) 0.355
Low anterior resection 12.7% 10.2% (6) 32.3% (10) < 0.05
Fistula surgery 4.4% 3.4% (2) 6.5% (2) 0.606
Haemorrhoidectomy 12.2% 11.9% (7) 12.9% (4) 1.000
Pelvic radiotherapy 13.3% 6.8% (4) 25.8% (8) < 0.05
Table 2. Pathophysiology of Fecal Incontinence
Pathophysiology Total Women Men P-value
Impaired EAS function 73.6% 96.5% 30.0% < 0.001
Impaired IAS function 60.9% 70.2% 43.3% < 0.05
Impaired extrinsic EAS reflexes 6.0% 7.3% 3.4% 0.655
Increased rectal sensitivity 11.7% 11.1% 13.0% 0.677
Reduced rectal sensitivity 9.1% 1.9% 26.1% < 0.01
EAS, external anal sphincter; IAS, internal anal sphincter. 
Table 3. Pathogenesis of Fecal Incontinence
Pathogenesis Total Women Men
Thekkinkattil classes
    Trauma 74.2% (66) 91.4% (53) 41.9% (13)
    Combined 7.9% (7) 3.4% (2) 16.1% (5)
    Neuropathic 2.2% (2) 1.7% (1) 3.2% (2)
    Idiopathic 15.7% (14) 3.4% (2) 38.7% (12)
Muñoz-Duyos classes
    Obstetric 46.1% (41) 70.7% (41) -
    Muscular non-obstetric 14.6% (13) 5.2% (3) 32.3% (10)
    Neuropathic 2.2% (2) 1.7% (1) 3.2% (1)
    Congenital 1.1% (1) - 3.2% (1)
    Multifactorial 30.3% (27) 22.4% (13) 45.2% (14)
    Idiopathic 5.6% (5) - 16.1% (5)
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Impact on Health and Quality of Life 
Although fecal incontinence had a strong impact on QoL in 
both sexes, women consistently scored worse than men in all sub-
scales, and those differences were statistically significant (Table 5). 
Differences between sexes remained when severity was divided in 
two groups (lower and higher), a Wexner score of 9 being the cut-
point (Table 6).
Overall, EQ-5D results showed differences between men 
and women that were statistically significant for anxiety/depres-
sion. Regarding the visual analogue scale, there were no statistically 
significant differences between the sexes, with patients reporting 
intermediate scores—mean (SD) 65.63 (16.39)—for self-perceived 
health status. The calculation of EQ-5D index from the descriptive 
data showed that women had poorer health status than men, with 
statistically significant differences (Table 7).
Correlation and Multivariate Regression Analyses
We found significantly negative correlation between the Wexner 
and Vaizey clinical severity scales and QoL as measured using the 
FIQL. Correlations between the 2 fecal incontinence severity scales 
and each FIQL subscale were moderate (–0.393 to 0.652). No 
correlation was found between duration of the condition and QoL. 
Finally, correlation between the Wexner and Vaizey severity scales 
was r = 0.92. 
The multivariate regression analysis to assess the independent 
effects on QoL of sex, age, severity (Wexner score) and depression 
revealed that greater severity, anxiety/depression, and female sex 
reduced QoL, whereas each additional year of age increased the 
FIQL score by 0.055 points (Table 8). 
Table 4. Fecal Incontinence Severity Scores 
Severitya Total Women Men
Wexner score 10.56 (4.34) 10.95 (4.35) 9.81 (4.3)
Vaizey score 12.80 (4.87) 13.27 (4.66) 11.90 (5.22)
Correlation 0.903 (P < 0.001) 0.907 (P < 0.001) 0.903 (P < 0.001)
aWexner and Vaizey scores expressed as mean (SD). 
Table 5. Fecal Incontinence Quality of Life Mean Scores 
Mean scoresa Total Women Men P-value
Depression 3.19 3.06 (0.64) 3.44 (0.56) < 0.001
Embarrassment 2.77 2.61 (0.80) 3.09 (0.73) < 0.01
Lifestyle 3.19 3.02 (0.83) 3.506 (0.67) < 0.01
Coping 2.51 2.27 (0.86) 2.97 (0.08) < 0.001
Overall 11.66 10.97 13.02 < 0.001
aThe maximum score for each subscale is 4, with higher numbers indicating a lower impact. 
Fecal Incontinence Quality of Life scores expressed as mean (SD).
Table 6. Fecal Incontinence Quality of Life Mean Scores According to Severity Score of Wexner Above or Below 9
Total Women Men P-value
Wexner < 9
    Depression 3.48 3.3 (0.60) 3.76 (0.10) < 0.05
    Embarrassment 3.28 3.11 (0.67) 3.57 (0.33) < 0.05
    Lifestyle 3.63 3.43 (0.70) 3.97 (0.64) < 0.05
    Coping 3.13 2.80 (0.87) 3.68 (0.23) < 0.01
Wexner ≥ 9
    Depression 3.06 2.96 (0.63) 3.26 (0.62) 0.087
    Embarrassment 2.53 2.39 (0.77) 2.83 (0.76) < 0.05
    Lifestyle 2.97 2.84 (0.82) 3.25 (0.71) < 0.05
    Coping 2.21 2.04 (0.75) 2.58 (0.72) < 0.01
Fecal Incontinence Quality of Life scores expressed as mean (SD).
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Discussion  
Our main finding was that, for the same clinical severity, fecal 
incontinence had a greater impact on QoL in women compared 
to men, with statistically significant differences for each individual 
FIQL subscales and in the EQ-5D index. In addition, these differ-
ences between the sexes persisted when the sample was divided in 
2 groups, one with Wexner < 9 and the other with Wexner ≥ 9, as 
a suggested cutpoint where FI affects significantly QoL.36,41 A sec-
ondary finding was that the pathophysiology of fecal incontinence 
differed significantly between men and women, although clinical 
symptoms were similar. 
Our results suggest—all other factors being equal—that the 
patient’s sex has a greater impact on QoL than severity, age and 
anxiety/depression. In fact, more than 4 additional Wexner scale 
points were necessary to overcome the effect of being female. Our 
results are consistent with those of Alsheik et al,7 although in that 
study all four FIQL subscales were combined, and partially with 
Cohan’s,32 who found male gender to be significantly associated 
with improved coping and embarrassment scores. However, other 
studies did not find significant differences between the sexes30 or re-
ported an improved life style scoring associated with being female.31 
Differences in impact on QoL in women versus men might be ex-
plained by different social expectations, as personal image has tradi-
tionally been considered more important for women. A woman with 
fecal incontinence may experience a certain dissonance regarding 
this expected image, making her prone to depression and even to so-
cial isolation. This social influence could also explain the differences 
Table 7. EQ-5D Results
Health status Total Women Men P-value
Mobility (%) 0.188
    No problems 78.9 74.6 87.1
    Moderate problems 21.1 25.4 12.9
    Major problems 0.0 0.0 0.0
Self-care (%) 1.000
    No problems 96.7 96.6 96.8
    Moderate problems 3.3 3.39 3.2
    Major problems 0.0 0.0 0.0
Usual activities (%) 0.318
    No problems 87.8 84.7 93.5
    Moderate problems 12.2 15.3 6.5
    Major problems 0.0 0.0 0.0
Pain/discomfort (%) 0.220
    No problems 40.0 35.6 48.4
    Moderate problems 50.0 50.8 48.4
    Major problems 10.0 13.6 3.2
Anxiety/depression (%) < 0.05
    No problems 51.1 40.7 71.0
    Moderate problems 35.6 39.0 29.0
    Major problems 13.3 20.3 0.0
Health progression (%) < 0.05
    Better than 1 year ago 23.3 15.3 38.7
    Same as 1 year ago 43.3 47.5 35.5
    Poorer than 1 year ago 33.3 37.3 25.8
VAS (self-perceived health status)  65.63 (16.39) 63.76 (17.18) 69.19 (14.38) 0.116
EQ-5D index 0.738 (0.20) 0.687 (0.20) 0.835 (0.15) < 0.001
VAS, visual analogue scale.
Table 8. Impact of Severity, Sex, Age, and Depression 
βa P-value
Wexner score (each additional point) –0.302 < 0.001
Being female –1.336 < 0.01
Age (each year older) 0.055 < 0.01
Anxiety/depression –1.324 < 0.01
aImpact on Fecal Incontinence Quality of Life (FIQL).
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with other studies where social contexts may be slightly different.
The role of anorectal testing in fecal incontinence has been ex-
tensively discussed.42 While some authors have argued that patients 
can be treated empirically,43 others have recommended systematic 
ARM and US imaging for objective evaluation of anorectal struc-
ture and function to decide on a treatment strategy.18,44 Our opinion 
is that ARM and US imaging are essential to achieve a clear idea of 
the subjacent pathophysiology.
Our finding of differences in male and female pathophysiology 
and pathogenesis has been corroborated by other studies.45,46 Essen-
tially, more women have an impaired EAS function (in our study, 
almost all the women compared to just one third of men), whereas 
impaired IAS function is common in both sexes (in our study, 
around three quarters of the women and almost half of the men). 
These data would explain the predominance of passive fecal incon-
tinence in men and of passive and urge incontinence in women, as 
reported in other studies.47
Almost half the patients in our study showed a tendency to-
wards diarrhea, indicated by Bristol stool chart scores of 5 or 6; 
some of these patients had severe gastroenterological diseases that 
typically present with diarrhea, primarily irritable bowel syndrome 
(18.6% of the women and 9.7% of the men in our study). Data on 
fecal consistency, which is frequently not systematically recorded in 
routine practice, is of great importance in the management of pa-
tients with fecal incontinence.
As would be expected, severity correlated negatively with QoL, 
with both the Wexner and Vaizey scales giving similar results. The 
FIQL dimensions with the poorest scores were coping and em-
barrassment, suggesting that embarrassment was a common and 
deeply felt emotion, with patients investing great efforts in strategies 
to avoid incontinence episodes. Even though pathophysiology and 
pathogenesis differed between men and women, overall fecal incon-
tinence severity was not significantly different between the sexes. 
The high correlation between the Wexner and Vaizey scores 
(r = 0.92) may suggest that the Vaizey score does not add any rel-
evant information to the Wexner score. However, we consider that 
the Vaizey score, even if quantitatively similar to the Wexner scale, 
has an additional qualitative dimension because it accounts for the 
ability to defer defecation. In our opinion, this issue further under-
lines the importance of routine QoL assessments of patients whose 
lives are conditioned by their efforts to deal with incontinence epi-
sodes: a patient with a low clinical severity score may, in fact, have a 
very restricted social life if this is felt to be conditioned by the ability 
to defer defecation. 
One of the limitations in our study was that we had fewer men 
than women. This could be because men seem to be more reluctant 
to consult about this condition, as mentioned earlier.4,8
Our study clearly shows that clinical severity alone is just one 
aspect of fecal incontinence. Even if severity is moderate or mild, fe-
cal incontinence is very likely to affect QoL, with women appearing 
to be particularly negatively affected. Managing patients with fecal 
incontinence can be complex. Considering QoL aspects is essential 
in clinical practice, as improving QoL is the final objective in this 
condition. Thus, knowledge of all the factors influencing QoL is of 
great importance, and sex can be one of them.
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